BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

NanoString Technologies Inc. 

201 Elliott Avenue West
Suite 300
Seattle  Washington  98119  U.S.A.
Phone: 206-378-NANO Fax: 206-378-6288


SEARCH JOBS




Industry
Diagnostics






 Company News
Merck & Co. (MRK) And NanoString (NSTG) Announce Clinical Research Collaboration To Develop An Immune-Related Gene Expression Assay For Use In The Development Program For KEYTRUDA (Pembrolizumab) 5/28/2015 9:43:15 AM
Four Seattle Biotech Firms Looking to Hire Hundreds of New Employees 5/21/2015 6:31:28 AM
NanoString (NSTG) Announces Favorable Draft Local Coverage Determination By Palmetto GBA For Its Prosigna Breast Cancer Assay 5/15/2015 7:20:23 AM
NanoString (NSTG) Release: St. Gallen International Breast Cancer Guidelines Recognize Power Of Prosigna/PAM50 To Inform Treatment Decisions And Spare Low Risk Breast Cancer Patients Unnecessary Chemotherapy 5/12/2015 7:44:44 AM
NanoString (NSTG) To Present At The UBS Global Healthcare Conference 5/7/2015 12:12:31 PM
NanoString (NSTG) Releases Financial Results For First Quarter Of 2015 5/7/2015 8:26:24 AM
NanoString (NSTG) Reports 35 Percent Loss, Remains Positive, Ramps Up Hiring 5/7/2015 6:23:08 AM
NanoString (NSTG) And Cancer Immunotherapy Trials Network (CITN) Enter Into A Collaboration To Identify Biomarker Assays For Novel Cancer Immunotherapies 5/6/2015 7:22:43 AM
NanoString (NSTG) To Release First Quarter 2015 Financial Results And Host Conference Call On Wednesday, May 6, 2015 4/23/2015 10:34:38 AM
NanoString (NSTG) Empowers Cancer Researchers With Three Innovative New Products For The Ncounter Analysis System 4/17/2015 8:47:55 AM
12345678910...